Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CSF Dynamic MRI Study with PSO17 in Normal Pressure Hydrocephalus and Dementia
jRCTs011190003Active, not recruiting
- Sponsor
- Japan Agency for Medical Research and Development
- Start
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of H2^17O saline in normal pressure hydrocephalus (NPH), Alzheimer's disease (AD), Dementia and 1 more, sponsored by Japan Agency for Medical Research and Development. Primary endpoint: Safety of intrathecal PSO17. Started Sep 2019; status: active, not recruiting.
02
Drugs
H2^17O saline
03
Conditions
normal pressure hydrocephalus (NPH)Alzheimer's disease (AD)DementiaMild Cognitive Impairment (MCI)
Beyond the preview
Go deeper on jRCTs011190003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs011190003.